<VariationArchive RecordType="classified" VariationID="39805" VariationName="NM_003106.4(SOX2):c.837del (p.Gly280fs)" VariationType="Deletion" Accession="VCV000039805" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-17" DateCreated="2018-01-23" MostRecentSubmission="2018-01-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="48404" VariationID="39805">
      <GeneList>
        <Gene Symbol="SOX2" FullName="SRY-box transcription factor 2" GeneID="6657" HGNC_ID="HGNC:11195" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181711925" stop="181714436" display_start="181711925" display_stop="181714436" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181429711" stop="181432223" display_start="181429711" display_stop="181432223" Strand="+" />
          </Location>
          <OMIM>184429</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SOX2-OT" FullName="SOX2 overlapping transcript" GeneID="347689" HGNC_ID="HGNC:20209" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181056680" stop="181742228" display_start="181056680" display_stop="181742228" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181328150" stop="181459008" display_start="181328150" display_stop="181459008" Strand="+" />
          </Location>
          <OMIM>616338</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003106.4(SOX2):c.837del (p.Gly280fs)</Name>
      <CanonicalSPDI>NC_000003.12:181713193:CCCC:CCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q26.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181713194" stop="181713194" display_start="181713194" display_stop="181713194" variantLength="1" positionVCF="181713193" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181430982" stop="181430982" display_start="181430982" display_stop="181430982" variantLength="1" positionVCF="181430981" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G280fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.181430985del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.181430985del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.181713197del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.181713197del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009080.1" sequenceAccession="NG_009080" sequenceVersion="1" change="g.6264del">
            <Expression>NG_009080.1:g.6264del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003106.4" sequenceAccession="NM_003106" sequenceVersion="4" change="c.837del" MANESelect="true">
            <Expression>NM_003106.4:c.837del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003097.1" sequenceAccession="NP_003097" sequenceVersion="1" change="p.Gly280fs">
            <Expression>NP_003097.1:p.Gly280fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_719" sequenceAccession="LRG_719" change="g.6264del">
            <Expression>LRG_719:g.6264del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="398122916" DB="dbSNP" />
        <XRef ID="CA261227" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="184429.0019" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003106.4(SOX2):c.837del (p.Gly280fs) AND Anophthalmia/microphthalmia-esophageal atresia syndrome" Accession="RCV000033026" Version="21">
        <ClassifiedConditionList TraitSetID="3485">
          <ClassifiedCondition DB="MedGen" ID="C1859773">Anophthalmia/microphthalmia-esophageal atresia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-07-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-01-23" MostRecentSubmission="2018-01-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21326281</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3485" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5530" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Microphthalmia and esophageal atresia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia clinical with associated anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia esophageal genital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AEG syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia microphthalmia esophageal atresia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Anophthalmia/microphthalmia-esophageal atresia syndrome</ElementValue>
                <XRef ID="MONDO:0008799" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microphthalmia syndromic 3</ElementValue>
                <XRef ID="Microphthalmia+syndromic+3/4787" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MCOPS3</ElementValue>
                <XRef Type="MIM" ID="206900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of SOX2 disorder includes anophthalmia and/or microphthalmia, brain malformations, developmental delayÂ / intellectual disability, esophageal atresia, hypogonadotropic hypogonadism (manifest as cryptorchidism and micropenis in males, gonadal dysgenesis infrequently in females, and delayed puberty in both sexes), pituitary hypoplasia, postnatal growth delay, hypotonia, seizures, and spastic or dystonic movements.</Attribute>
                <XRef ID="NBK1300" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1443" />
                <XRef ID="1443" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2 Disorder</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2 anophthalmia syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2-related eye disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2-Related Eye Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301477</ID>
                <ID Source="BookShelf">NBK1300</ID>
              </Citation>
              <XRef ID="77298" DB="Orphanet" />
              <XRef ID="C1859773" DB="MedGen" />
              <XRef ID="MONDO:0008799" DB="MONDO" />
              <XRef Type="MIM" ID="206900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="94009" SubmissionDate="2018-01-19" DateLastUpdated="2018-01-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="184429.0019_MICROPHTHALMIA, SYNDROMIC 3" title="SOX2, 1-BP DEL, 837C_MICROPHTHALMIA, SYNDROMIC 3" />
        <ClinVarAccession Accession="SCV000056806" DateUpdated="2018-01-23" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 8-year-old boy with bilateral clinical anophthalmia and endocrinologic abnormalities (MCOPS3; 206900) and his sister who had only unilateral microphthalmia, Stark et al. (2011) identified heterozygosity for a 1-bp deletion (837delC) in the SOX2 gene, predicted to cause a frameshift and addition of 90 abnormal C-terminal residues (Gly208AlafsTer91). The boy had transient growth and growth hormone disturbances in infancy, but was not dysmorphic and had descended testes with a normal phallus; subsequently his growth normalized and pituitary function was normal on yearly monitoring. MRI of the brain at 1 year of age showed no eye remnants and absent optic nerves, an intact corpus callosum and a normal pituitary, but a dysplastic right hippocampus. His 8-month-old sister had left microphthalmia and a large left retinal coloboma, but no associated anomalies or dysmorphic features. Their mother, who had been evaluated at 18 years of age for primary amenorrhea and limited development of secondary sexual characteristics and was diagnosed with isolated hypogonadotropic hypogonadism, had a normal sense of smell, no dysmorphism, and a normal ophthalmologic examination. Sequencing results from the mother's lymphocyte DNA showed the presence of the mutation but at lower levels compared to her children, suggesting possible mosaicism. The unaffected father's sequencing results were normal.</Attribute>
              <Citation>
                <ID Source="PubMed">21326281</ID>
              </Citation>
              <XRef DB="OMIM" ID="206900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <Name>SOX2, 1-BP DEL, 837C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 837C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="184429.0019" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MICROPHTHALMIA, SYNDROMIC 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="94009" TraitType="Disease" MappingType="Name" MappingValue="MICROPHTHALMIA, SYNDROMIC 3" MappingRef="Preferred">
        <MedGen CUI="C1859773" Name="Anophthalmia/microphthalmia-esophageal atresia syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

